CHINAAMC Hang Seng Biotech ETF (HKG:9069)

Assets	2.63B
Expense Ratio	0.75%
PE Ratio	22.03
Dividend (ttm)	0.05
Dividend Yield	0.30%
Ex-Dividend Date	Dec 18, 2025
Payout Frequency	Annual
Payout Ratio	54.68%
1-Year Return	-4.36%

Volume	45,500
Open	2.136
Previous Close	2.120
Day's Range	2.118 - 2.136
52-Week Low	1.498
52-Week High	2.366
Beta	n/a
Holdings	10
Inception Date	Mar 18, 2021

About 9069

CHINAAMC Hang Seng Biotech ETF is headquartered in Beijing, China.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 9069
• Provider: ChinaAMC
• Index Tracked: Hang Seng Biotech Index - HKD - Benchmark TR Net

Performance

9069 had a total return of -4.36% in the past year, including dividends. Since the fund's inception, the average annual return has been -9.32%.

Top Holdings

68.76% of assets

Name	Symbol	Weight
Innovent Biologics, Inc.	1801	10.03%
BeOne Medicines AG	6160	10.03%
WuXi Biologics (Cayman) Inc.	2269	9.78%
WuXi AppTec Co., Ltd.	2359	8.31%
Akeso, Inc.	9926	7.23%
CSPC Pharmaceutical Group Limited	1093	6.27%
Sino Biopharmaceutical Limited	1177	5.07%
Hansoh Pharmaceutical Group Company Limited	3692	5.00%
3SBio Inc.	1530	3.82%
Citigroup Global Markets Holdings Inc.	C.0 02.18.27 000A	3.21%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 18, 2025	0.050 HKD	Dec 31, 2025
Dec 18, 2024	0.06001 HKD	Dec 31, 2024
Dec 18, 2023	0.02996 HKD	Dec 29, 2023
Dec 19, 2022	0.03999 HKD	Dec 30, 2022

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error